Bart van Berckel
Bart van Berckel
Professor of Molecular Brain Imaging, Amsterdam University Medical Center
確認したメール アドレス:
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C] PK11195 positron emission tomography study
BN Van Berckel, MG Bossong, R Boellaard, R Kloet, A Schuitemaker, ...
Biological psychiatry 64 (9), 820-822, 2008
The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials
C Groot, AM Hooghiemstra, PGHM Raijmakers, BNM van Berckel, ...
Ageing research reviews 25, 13-23, 2016
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
Δ9-tetrahydrocannabinol induces dopamine release in the human striatum
MG Bossong, BN Van Berckel, R Boellaard, L Zuurman, RC Schuit, ...
Neuropsychopharmacology 34 (3), 759-766, 2009
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment
MAA Binnewijzend, MM Schoonheim, E Sanz-Arigita, AM Wink, ...
Neurobiology of aging 33 (9), 2018-2028, 2012
The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
R Ossenkoppele, YAL Pijnenburg, DC Perry, BI Cohn-Sheehy, ...
Brain 138 (9), 2732-2749, 2015
Optimizing patient care and research: the Amsterdam Dementia Cohort
WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ...
Journal of Alzheimer's disease 41 (1), 313-327, 2014
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ...
Brain 135 (1), 181-189, 2012
Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity
MAA Binnewijzend, JPA Kuijer, MR Benedictus, WM van der Flier, ...
Radiology 267 (1), 221-230, 2013
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0
DSW Djang, MJR Janssen, N Bohnen, J Booij, TA Henderson, K Herholz, ...
Journal of Nuclear Medicine 53 (1), 154-163, 2012
Effect of age on functional P‐glycoprotein in the blood‐brain barrier measured by use of (R)‐[11C]verapamil and positron emission tomography
R Toornvliet, BNM van Berckel, G Luurtsema, M Lubberink, AA Geldof, ...
Clinical Pharmacology & Therapeutics 79 (6), 540-548, 2006
Reduced GABA A benzodiazepine receptor binding in veterans with post-traumatic stress disorder
E Geuze, BNM Van Berckel, AA Lammertsma, R Boellaard, CS De Kloet, ...
Molecular psychiatry 13 (1), 74-83, 2008
Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding
N Tolboom, WM van der Flier, M Yaqub, R Boellaard, NA Verwey, ...
Journal of Nuclear Medicine 50 (9), 1464-1470, 2009
Impact of molecular imaging on the diagnostic process in a memory clinic
R Ossenkoppele, ND Prins, YAL Pijnenburg, AW Lemstra, ...
Alzheimer's & Dementia 9 (4), 414-421, 2013
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
A Prestia, A Caroli, WM Van Der Flier, R Ossenkoppele, B Van Berckel, ...
Neurology 80 (11), 1048-1056, 2013
Atrophy patterns in early clinical stages across distinct phenotypes of A lzheimer's disease
R Ossenkoppele, BI Cohn‐Sheehy, R La Joie, JW Vogel, C Möller, ...
Human brain mapping 36 (11), 4421-4437, 2015
The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects
BNM van Berckel, B Oranje, JM van Ree, MN Verbaten, RS Kahn
Psychopharmacology 137 (3), 271-281, 1998
The effects of a sub-anaesthetic dose of ketamine on human selective attention
B Oranje, BNM Van Berckel, C Kemner, JM Van Ree, RS Kahn, ...
Neuropsychopharmacology 22 (3), 293-302, 2000
論文 1–20